NervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291

Press/Media: Press / Media

PeriodOct 20 2020

Media coverage

1

Media coverage

  • TitleNervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291
    Media name/outletImpact Financial News
    CountryUnited Kingdom
    Date10/20/20
    PersonsMichael A Davis